verapamil and carvedilol

verapamil has been researched along with carvedilol in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.38)	18.7374
1990's	4 (9.52)	18.2507
2000's	15 (35.71)	29.6817
2010's	20 (47.62)	24.3611
2020's	2 (4.76)	2.80

Authors

Authors	Studies
Behnam-Motlagh, P; Grankvist, K; Henriksson, R; Jonsson, O; Persson, M	1
Topliss, JG; Yoshida, F	1
Anger, T; Madge, DJ; Mulla, M; Riddall, D	1
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ	1
Keserü, GM	1
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Jia, L; Sun, H	1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z	1
Bard, B; Carrupt, PA; Martel, S	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Gozalbes, R; Pineda-Lucena, A	1
Sen, S; Sinha, N	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Filipek, B; Gryboś, A; Kubacka, M; Marona, H; Mogilski, S; Pańczyk, K; Siwek, A; Szkaradek, N; Waszkielewicz, AM; Żmudzki, P	1
Cantillon, DM; Derudas, M; Huckvale, R; Kenyon, EJ; Kirkwood, NK; Kros, CJ; O'Reilly, M; Richardson, GP; Waddell, SJ; Ward, SE	1
Betterridge, DJ; Gasser, JA	1
Bartsch, W; Böhm, E; Müller-Beckmann, B; Sponer, G; Strein, K; Voss, EM	1
Blackwood, RA; Garnham, S; Gunawardena, KA; Hauf-Zachariou, U; O'Donnell, JG; Pfarr, E	1
Lercher, P; Liebmann, P; Lindner, W; Maier, R; Sakotnik, A; Stoschitzky, K; Zweiker, R	1
Kakumoto, M; Kita, T; Kobayashi, H; Nakamura, T; Okamura, N; Okumura, K; Sakaeda, T; Takara, K; Yagami, T	1
Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C	1
Amioka, K; Ejiri, M; Kushihara, H; Kuzuya, T; Nabeshima, T; Nitta, A	1
Helewski, K; Lekston, A; Nowak, J; Nowalany-Kozielska, E; Poloński, L; Stolarz, W; Streb, W; Szyguła-Jurkiewicz, B; Wilczewski, P; Wojciechowska, C; Wojnicz, R	1
Bertera, FM; Chiappetta, D; Del Mauro, JS; Höcht, C; Lovera, V; Polizio, AH; Taira, CA	1
Abdelnoor, M; Arnesen, H; Enger, S; Gjesdal, K; Pripp, AH; Tveit, A; Ulimoen, SR	1
Abdelnoor, M; Arnesen, H; Enger, S; Gjesdal, K; Norseth, J; Pripp, AH; Tveit, A; Ulimoen, SR	1
Corino, VD; Enger, S; Mainardi, LT; Platonov, PG; Tveit, A; Ulimoen, SR	1
Bertsch, T; Christ, M; Fey, H; Geise, AT; Jost, M	1
Hrstka, SC; Nelson, TJ; Olson, TM; Reyes, S; Terzic, A; Wyles, SP	1
Arnesen, H; Enger, S; Horjen, AW; Norseth, J; Seljeflot, I; Tveit, A; Ulimoen, SR	1
Chen, H; Chen, X; Guo, H; Niu, X; Pan, C; Yi, T	1
Degim, T; Ilbasmis-Tamer, S; Incecayir, T; Tirnaksiz, F	1
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B	1
Chang, S; Lu, S; Shen, L; Tong, X; Wang, Y; Zhou, X	1
Ashley, EA; Bernstein, D; Huang, Y; Kawana, M; Kirillova, A; Lane, KV; Parikh, VN; Perez, MV; Pruitt, BL; Seo, K; Wang, Q; Wheeler, MT; Wu, JC; Yadav, S; Yamamoto, Y	1

Reviews

3 review(s) available for verapamil and carvedilol

Article	Year
Medicinal chemistry of neuronal voltage-gated sodium channel blockers. Journal of medicinal chemistry, 2001, Jan-18, Volume: 44, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke	2001
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis. Drugs in R&D, 2023, Volume: 23, Issue:3 Topics: Cardiomyopathy, Dilated; Carvedilol; Humans; Ivabradine; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke Volume; Trimetazidine; Ventricular Function, Left; Verapamil	2023

Trials

7 trial(s) available for verapamil and carvedilol

Article	Year
Carvedilol versus verapamil in chronic stable angina: a multicentre trial. European journal of clinical pharmacology, 1997, Volume: 52, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Chronic Disease; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Propanolamines; Vasodilator Agents; Verapamil	1997
Influence of beta-blockers on melatonin release. European journal of clinical pharmacology, 1999, Volume: 55, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Carbazoles; Carvedilol; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Hemodynamics; Humans; Male; Melatonin; Propanolamines; Propranolol; Stereoisomerism; Verapamil	1999
Therapeutic window for calcium-channel blockers in the management of dilated cardiomyopathy: a prospective, two-centre study on non-advanced disease. Cardiology, 2010, Volume: 117, Issue:2 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diastole; Drug Therapy, Combination; Exercise Tolerance; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mitral Valve; Propanolamines; Prospective Studies; Severity of Illness Index; Vasodilator Agents; Ventricular Function, Left; Verapamil	2010
Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. European heart journal, 2014, Volume: 35, Issue:8 Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Calcium Channel Blockers; Carbazoles; Carvedilol; Cross-Over Studies; Delayed-Action Preparations; Diltiazem; Exercise Tolerance; Female; Humans; Male; Metoprolol; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Propanolamines; Prospective Studies; Verapamil	2014
Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation. Clinical cardiology, 2014, Volume: 37, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Carbazoles; Carvedilol; Cross-Over Studies; Diltiazem; Down-Regulation; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Norway; Propanolamines; Prospective Studies; Time Factors; Treatment Outcome; Troponin T; Verapamil	2014
Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation. Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:2 Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Carbazoles; Carvedilol; Cross-Over Studies; Diltiazem; Electrocardiography, Ambulatory; Female; Heart Conduction System; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Norway; Propanolamines; Time Factors; Treatment Outcome; Verapamil	2015
Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing. BMC cardiovascular disorders, 2016, May-04, Volume: 16 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Calcium Channel Blockers; Carbazoles; Carvedilol; Cross-Over Studies; Diltiazem; Down-Regulation; Exercise Test; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Norway; Predictive Value of Tests; Propanolamines; Treatment Outcome; Troponin I; Troponin T; Verapamil	2016

Other Studies

32 other study(ies) available for verapamil and carvedilol

Article	Year
Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. Biochemical pharmacology, 1999, Dec-01, Volume: 58, Issue:11 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carbazoles; Carvedilol; Cell Division; Doxorubicin; Drug Synergism; Fluoresceins; Fluorescence; Free Radicals; Humans; Propanolamines; Pyrogallol; Tumor Cells, Cultured; Verapamil	1999
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors. Biochemical and biophysical research communications, 2001, Nov-30, Volume: 289, Issue:2 Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors	2001
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents. Bioorganic & medicinal chemistry letters, 2004, Sep-20, Volume: 14, Issue:18 Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2004
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
First-principle, structure-based prediction of hepatic metabolic clearance values in human. European journal of medicinal chemistry, 2009, Volume: 44, Issue:4 Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software	2009
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography. Journal of medicinal chemistry, 2009, May-28, Volume: 52, Issue:10 Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone. Bioorganic & medicinal chemistry, 2018, 07-30, Volume: 26, Issue:13 Topics: Adrenergic Antagonists; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Drug Design; Heart Rate; Inhibitory Concentration 50; Male; Platelet Aggregation; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Structure-Activity Relationship; Verapamil; Xanthones	2018
Design, Synthesis, and Biological Evaluation of a New Series of Carvedilol Derivatives That Protect Sensory Hair Cells from Aminoglycoside-Induced Damage by Blocking the Mechanoelectrical Transducer Channel. Journal of medicinal chemistry, 2019, 06-13, Volume: 62, Issue:11 Topics: Aminoglycosides; Animals; Carvedilol; Chemistry Techniques, Synthetic; Cytoprotection; Dose-Response Relationship, Drug; Drug Design; Electrophysiological Phenomena; Hair Cells, Auditory; Mechanotransduction, Cellular; Mice; Zebrafish	2019
Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers. Journal of cardiovascular pharmacology, 1991, Volume: 18 Suppl 4 Topics: Adrenergic beta-Antagonists; Blood Platelets; Carbazoles; Carvedilol; Coronary Disease; Cyclic AMP; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Propanolamines; Propranolol; Thromboxane B2; Vasodilator Agents; Verapamil	1991
Comparison of the haemodynamic profiles of the hypotensive action of verapamil and carvedilol. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1985, Volume: 3, Issue:3 Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Dogs; Hemodynamics; Propanolamines; Verapamil	1985
Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Cancer science, 2003, Volume: 94, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Carbazoles; Carvedilol; Cell Division; Cell Line; Daunorubicin; Digoxin; DNA, Complementary; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelial Cells; Fluorouracil; HeLa Cells; Humans; Inhibitory Concentration 50; Kidney; Paclitaxel; Propanolamines; Swine; Transfection; Verapamil; Vinblastine	2003
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Mar-01, Volume: 847, Issue:2 Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil	2007
Carvedilol increases ciclosporin bioavailability by inhibiting P-glycoprotein-mediated transport. The Journal of pharmacy and pharmacology, 2007, Volume: 59, Issue:10 Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Calcium Channel Blockers; Carbazoles; Carvedilol; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunosuppressive Agents; Injections, Intravenous; Intestinal Absorption; Male; Propanolamines; Rats; Rats, Wistar; Verapamil	2007
Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:4 Topics: Adrenergic beta-Antagonists; Animals; Arterial Pressure; Atenolol; Benzopyrans; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Denervation; Dose-Response Relationship, Drug; Ethanolamines; Heart Rate; Male; Nebivolol; Propanolamines; Rats; Rats, Wistar; Sinoatrial Node; Verapamil	2013
[Cardiogenic shock after drug therapy for atrial fibrillation with tachycardia : Case report of an 89-year-old woman]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2016, Volume: 111, Issue:5 Topics: Aged, 80 and over; Atrial Fibrillation; Carbazoles; Carvedilol; Critical Care; Drug Interactions; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Propanolamines; Shock, Cardiogenic; Tachycardia; Verapamil	2016
Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model. Clinical and translational science, 2016, Volume: 9, Issue:3 Topics: Apoptosis; Calcium; Calcium Signaling; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Homeostasis; Humans; Induced Pluripotent Stem Cells; Models, Biological; Myocytes, Cardiac; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; RNA-Binding Proteins; Sarcomeres; Stress, Physiological; Verapamil	2016
A novel in situ strategy for the preparation of a β-cyclodextrin/polydopamine-coated capillary column for capillary electrochromatography enantioseparations. Journal of separation science, 2017, Volume: 40, Issue:12 Topics: beta-Cyclodextrins; Capillary Electrochromatography; Carbazoles; Carvedilol; Epinephrine; Indoles; Isoproterenol; Norepinephrine; Polymers; Propanolamines; Stereoisomerism; Terbutaline; Tryptophan; Verapamil	2017
Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein. Die Pharmazie, 2016, 08-01, Volume: 71, Issue:8 Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbazoles; Carvedilol; Clopidogrel; Drug Interactions; Intestinal Absorption; Intestine, Small; Male; Metoprolol; Perfusion; Permeability; Platelet Aggregation Inhibitors; Propanolamines; Rats; Rats, Wistar; Ticlopidine; Verapamil	2016
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019, Oct-15, Volume: 1129 Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil	2019
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. Circulation, 2023, Nov-21, Volume: 148, Issue:21 Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Carvedilol; Humans; Metoprolol; Mice; Myocytes, Cardiac; Receptors, Adrenergic; Ryanodine Receptor Calcium Release Channel; Verapamil	2023